SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-21-010979
Filing Date
2021-05-24
Accepted
2021-05-24 16:54:41
Documents
85
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q tlgt-20210331.htm   iXBRL 10-Q 1594117
2 EX-31.1 tlgtq12021ex311.htm EX-31.1 10067
3 EX-31.2 tlgtq12021ex312.htm EX-31.2 10332
4 EX-32.1 tlgtq12021ex321.htm EX-32.1 5028
5 EX-32.2 tlgtq12021ex322.htm EX-32.2 5507
  Complete submission text file 0001628280-21-010979.txt   9629546

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tlgt-20210331.xsd EX-101.SCH 62661
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT tlgt-20210331_cal.xml EX-101.CAL 95107
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT tlgt-20210331_def.xml EX-101.DEF 419850
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tlgt-20210331_lab.xml EX-101.LAB 817664
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tlgt-20210331_pre.xml EX-101.PRE 608664
11 EXTRACTED XBRL INSTANCE DOCUMENT tlgt-20210331_htm.xml XML 1701207
Mailing Address 105 LINCOLN AVENUE BUENA NJ 08310
Business Address 105 LINCOLN AVENUE BUENA NJ 08310 856.697.1441
Teligent, Inc. (Filer) CIK: 0000352998 (see all company filings)

IRS No.: 010355758 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-08568 | Film No.: 21955716
SIC: 2834 Pharmaceutical Preparations